Release Date: 02/05/22 07:51 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 9.07MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%